Prostate cancer screening is one of the most common decisions men face in primary care, yet many patients make that choice without fully understanding the potential benefits and harms. A new editorial by physician experts from the University of North Carolina argues that shared decision-making should no longer depend on individual clinician effort but instead be built into health care systems. The authors propose a systems-based approach that integrates decision support tools, patient education, and standardized processes into routine care.

  • Current gaps: Many men undergo prostate cancer screening without a balanced discussion of risks and benefits.
  • Proposed solution: Health systems should embed shared decision-making into workflows, not leave it to individual doctors.
  • Key tools: Decision aids, risk calculators, and structured conversations can help patients make informed choices.
  • Potential impact: A systems approach could reduce unnecessary biopsies and overtreatment while respecting patient preferences.

The Problem with Current Screening Discussions

Prostate-specific antigen (PSA) testing remains a controversial topic in primary care. While it can detect early-stage prostate cancer, it also leads to false positives, overdiagnosis, and unnecessary treatments that may cause side effects like incontinence and erectile dysfunction. Guidelines from groups like the U.S. Preventive Services Task Force recommend shared decision-making for men aged 55 to 69, meaning clinicians should discuss the pros and cons before ordering a PSA test.

In practice, however, these conversations often fall short. Time constraints, lack of training, and inconsistent use of decision aids mean many men receive a test without truly understanding the trade-offs. The UNC editorial, published in JAMA Internal Medicine, highlights that relying on individual clinicians to initiate and conduct these discussions is unreliable. Patients from different backgrounds may not receive the same quality of counseling, leading to inequities in screening decisions.

What a Systems-Based Approach Looks Like

The authors call for health systems to take responsibility for ensuring that every eligible patient has access to balanced information before screening. This could involve automated reminders for clinicians, integration of decision aids into electronic health records, and pre-visit questionnaires that prompt patients to consider their values and preferences.

For example, a patient scheduled for a routine physical might receive a short video or pamphlet explaining the risks and benefits of PSA testing before the appointment. During the visit, the clinician could use a shared decision-making tool that displays personalized risk estimates based on age, race, and family history. The system would then document the discussion and the patient’s choice, ensuring accountability.

Such an approach does not replace the clinician’s role but rather supports it. The goal is to make informed decision-making the default rather than an exception. The editorial notes that similar systems have been successfully implemented for other screening tests, such as colonoscopy and mammography.

Benefits of System Integration

Embedding shared decision-making into health care systems offers several advantages. First, it reduces the burden on individual clinicians, who often have limited time for complex discussions. Second, it standardizes the information patients receive, reducing disparities based on clinician communication style or patient health literacy. Third, it creates a clear record of the decision-making process, which can improve quality measurement and medicolegal protection.

The UNC experts also argue that a systems approach aligns with the broader movement toward patient-centered care. By providing tools and prompts, health systems can empower patients to ask questions and express their values, leading to decisions that better match individual preferences. This could ultimately reduce the number of men who undergo PSA testing without understanding the potential for harm, as well as those who avoid testing despite being at higher risk.

Potential Challenges and Considerations

Implementing a systems-based approach is not without hurdles. Health systems must invest in decision aid development, staff training, and electronic health record modifications. There is also the risk of overstandardization, where a one-size-fits-all tool may not account for unique patient circumstances or cultural differences.

Additionally, some clinicians may resist what they perceive as a loss of autonomy. The editorial emphasizes that the goal is not to dictate decisions but to ensure that every patient has the opportunity for an informed conversation. Systems should be flexible enough to accommodate clinician judgment and patient preference.

Finally, the authors note that evidence on the effectiveness of system-level interventions for prostate cancer screening is still emerging. More research is needed to determine which tools work best in different settings and for diverse populations.

Frequently Asked Questions

Why is shared decision-making important for prostate cancer screening?

Shared decision-making ensures that men understand the potential benefits and harms of PSA testing before deciding. Without it, patients may undergo screening that leads to unnecessary biopsies and treatments, or they may miss out on testing that could detect cancer early. The process respects individual values and preferences, which is especially important for a test with uncertain net benefit.

What does a systems-based approach mean in practice?

A systems-based approach integrates decision support into routine care workflows. Examples include automatic delivery of educational materials before appointments, use of risk calculators in electronic health records, and structured templates for documenting screening discussions. The goal is to make informed decision-making the standard rather than relying on individual clinicians to initiate conversations.

How can patients prepare for screening discussions?

Patients can review reliable information about PSA testing from sources like the U.S. Preventive Services Task Force or the American Cancer Society before their appointment. They should consider their personal risk factors, such as age, race, and family history, and think about how they value the trade-off between potential early detection and the risk of overdiagnosis. Asking their clinician about the evidence and expressing their concerns can lead to a more balanced conversation.

This is an original report by Vital Signs Today, informed by reporting from Medical Xpress. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.